Skip to main content

JANE STREET GROUP, LLC

Position in ADCT — ADC Therapeutics SA

CIK 1595888 NEW YORK, NY

Position in ADCT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$532,735
-$172,431 QoQ
Shares Held
142,063
-28.9% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Derivatives in ADCT

reported options exposure · as of Mar 31, 2026
CallValue
$47,625
CallShares
12,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $181,243,153 across 41 Drug Manufacturers - Specialty & Generic names. ADCT ranks #26 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADCT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $532,735 142,063
2026-03-31 $47,625 12,700
2025-12-31 $705,166 199,764
2025-09-30 $1,951,472 487,868
2025-06-30 $38,860 14,500
2024-09-30 $167,346 53,126
2024-06-30 $45,083 14,267
2024-03-31 $121,157 26,984
2023-12-31 $168,091 101,260
2023-06-30 $35,404 16,467
2023-03-31 $49,888 25,584
2021-06-30 $389,600 16,000